Showing results (41-50 of 206) with videos related to

Sort By:
Pageof 21
Psychopharmacology|June 16, 2019
Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humansShanna Babalonis, Michelle R Lofwall, Paul A Sloan, et al.
Psychopharmacology|May 25, 2012
Pharmacodynamic profile of tramadol in humans: influence of naltrexone pretreatmentWilliam W Stoops, Michelle R Lofwall, Paul A Nuzzo, et al.
Drug and Alcohol Dependence|January 15, 2017
Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokersShanna Babalonis, Margaret Haney, Robert J Malcolm, et al.
Drug and Alcohol Dependence|March 1, 2026
Buprenorphine utilization following removal of prior authorization requirements in the Kentucky Medicaid populationDustin K Miracle, Lindsey R Hammerslag, Svetla Slavova, et al.
Journal of Opioid Management|October 25, 2023
Contributions of a central registry to monitor methadone -treatment through the HEALing Communities StudyKatherine R Marks, Jeffery Talbert, Lindsey R Hammerslag, et al.
Frontiers in Psychiatry|January 24, 2022
Recent Increase in Methamphetamine Use in a Cohort of Rural People Who Use Drugs: Further Evidence for the Emergence of Twin EpidemicsJennifer R Havens, Hannah K Knudsen, Justin C Strickland, et al.
Experimental and Clinical Psychopharmacology|November 14, 2024
Residual next-day effects of alprazolam on psychomotor performance and simulated driving in healthy normal adultsStevie C Roszkowski, Shanna Babalonis, Marion A Coe, et al.
Journal of Viral Hepatitis|March 4, 2024
Predictors of engagement in screening for a hepatitis C virus (HCV) treatment trial in a rural Appalachian communityJennifer R Havens, Michelle R Lofwall, April M Young, et al.
Drug and Alcohol Dependence|December 4, 2012
Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trialSharon L Walsh, Lisa S Middleton, Conrad J Wong, et al.
Journal of Substance Use and Addiction Treatment|May 19, 2026
Organizational perspectives on barriers and facilitators to an integrated care model for opioid use disorder and serious injection-related infectionsHilary L Surratt, Michelle R Lofwall, Elizabeth O Nelson, et al.
Pageof 21